According to reports, Myr inhibits the proliferation of various cancer cells through multiple signaling pathways, including PI3K/AKT, PAK1/MEK/ERK1/2, cyclin D1/PCNA, STAT3 and so on (15, 16). This evidence concerns the gene AKT1 and cancer.